ArticleSisli Etfal Hastanesi tip bulteni2025
Comparison of Cardiac Findings in Pediatric Patients with Multisystem Inflammatory Syndrome in Children Associated with COVID-19.
Article in Sisli Etfal Hastanesi tip bulteni, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious hyperinflammatory complication of COVID-19 in which cardiovascular abnormalities are frequently detected. In the context of MIS-C, it remains uncertain which patients will develop cardiac dysfunction and which will experience coronary artery abnormalities (CAAs). To investigate this, patients were categorized into four distinct groups based on the presence or absence of myocardial dysfunction and/or CAAs. We aimed to determine whether there were any differences in demographic, echocardiographic, laboratory results, outcome, and COVID-19 variants between the groups. Methods: Between July 2020 and August 2022, 135 MIS-C diagnosed patients were divided into 4 groups according to their cardiovascular involvement. Results: The mean age of the patients was 104 months (9-209 months) and the male/female ratio was 1.45. Thirty-eight percent of the patients had decreased LVEF and 44% had signs of CAAs. Fifty-nine percent (80/135) of the patients were admitted to the pediatric intensive care unit (PICU). Patients admitted to the PICU were older patients with cardiac dysfunction. The severity of cardiac involvement ranged from severe to mild in Group 1, Group 2, Group 3, and Group 4, respectively. Group 1 was older (median age 146 months, p=0.008), albumin was lower (p=0.015) and CRP was higher than Group 4 (p=0.007). PICU admission/stay time and CRP elevation were significant in the groups with decreased LVEF (groups 1 and 2). More MIS-C patients were observed in the alpha wave compared to other waves, but there was no difference in the severity of cardiac involvement (p=0.25). Cardiac dysfunction and improvement in CAAs were observed in patients. The case fatality rate was 1.48%. Conclusion: D-dimer, CRP, ferritin levels were higher, lymphocyte, platelet and albumin levels were lower in elderly patients with cardiac dysfunction who were followed up in the PICU.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.